Mirum Pharmaceuticals, Inc. (MIRM)
92.66
+0.71
(+0.77%)
USD |
NASDAQ |
Nov 18, 16:00
92.66
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Total Return Level : 91.95 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 91.95 |
| November 16, 2026 | 91.58 |
| November 13, 2026 | 93.99 |
| November 12, 2026 | 93.33 |
| November 11, 2026 | 94.61 |
| November 10, 2026 | 94.42 |
| November 09, 2026 | 93.18 |
| November 06, 2026 | 93.72 |
| November 05, 2026 | 93.54 |
| November 04, 2026 | 96.97 |
| November 03, 2026 | 87.03 |
| November 02, 2026 | 85.74 |
| October 30, 2026 | 85.00 |
| October 29, 2026 | 86.39 |
| October 28, 2026 | 85.81 |
| October 27, 2026 | 85.56 |
| October 26, 2026 | 83.27 |
| October 23, 2026 | 80.39 |
| October 22, 2026 | 83.10 |
| October 21, 2026 | 83.44 |
| October 20, 2026 | 85.07 |
| October 19, 2026 | 82.24 |
| October 16, 2026 | 80.14 |
| October 15, 2026 | 82.39 |
| October 14, 2026 | 79.96 |
| Date | Value |
|---|---|
| October 13, 2026 | 79.62 |
| October 12, 2026 | 86.06 |
| October 09, 2026 | 86.01 |
| October 08, 2026 | 81.35 |
| October 07, 2026 | 80.64 |
| October 06, 2026 | 79.25 |
| October 05, 2026 | 81.43 |
| October 02, 2026 | 82.93 |
| October 01, 2026 | 83.92 |
| September 30, 2026 | 85.48 |
| September 29, 2026 | 87.54 |
| September 28, 2026 | 87.96 |
| September 25, 2026 | 89.70 |
| September 24, 2026 | 89.36 |
| September 23, 2026 | 89.32 |
| September 22, 2026 | 91.39 |
| September 21, 2026 | 92.00 |
| September 18, 2026 | 91.83 |
| September 17, 2026 | 98.82 |
| September 16, 2026 | 97.37 |
| September 15, 2026 | 93.90 |
| September 14, 2026 | 96.75 |
| September 11, 2026 | 98.22 |
| September 10, 2026 | 100.61 |
| September 09, 2026 | 98.30 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Incyte Corp. | 119.09 |
| Galectin Therapeutics, Inc. | 2.91 |
| TG Therapeutics, Inc. | 62.71 |
| Ardelyx, Inc. | 3.18 |
| Kodiak Sciences, Inc. | 96.80 |